Cargando…

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrisroe, Kathleen, Stevens, Wendy, Sahhar, Joanne, Rabusa, Candice, Nikpour, Mandana, Proudman, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341425/
https://www.ncbi.nlm.nih.gov/pubmed/28270192
http://dx.doi.org/10.1186/s13075-017-1250-z
_version_ 1782512987629682688
author Morrisroe, Kathleen
Stevens, Wendy
Sahhar, Joanne
Rabusa, Candice
Nikpour, Mandana
Proudman, Susanna
author_facet Morrisroe, Kathleen
Stevens, Wendy
Sahhar, Joanne
Rabusa, Candice
Nikpour, Mandana
Proudman, Susanna
author_sort Morrisroe, Kathleen
collection PubMed
description BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in this cohort, and an evaluation of factors influencing physician adherence to PAH screening guidelines. METHODS: Patient characteristics and results of PAH screening were determined in all patients enrolled in a SSc longitudinal cohort study. Adherence to PAH screening guidelines was assessed by a survey of Australian rheumatologists. Summary statistics, chi-square tests, univariate and multivariable logistic regression were used to determine the associations of risk factors with PAH. RESULTS: Among 1636 patients with SSc, 194 (11.9%) had PAH proven by right-heart catheter. Of these, 160 were detected by screening. The annual incidence of PAH was 1.4%. Patients with PAH diagnosed on subsequent screens, compared with patients in whom PAH was diagnosed on first screen, were more likely to have diffuse SSc (p = 0.03), be in a better World Health Organisation (WHO) Functional Class at PAH diagnosis (p = 0.01) and have less advanced PAH evidenced by higher mean six-minute walk distance (p = 0.03), lower mean pulmonary arterial pressure (p = 0.009), lower mean pulmonary vascular resistance (p = 0.006) and fewer non-trivial pericardial effusions (p = 0.03). Adherence to annual PAH screening using an ECHO-based algorithm was poor among Australian rheumatologists, with less than half screening their patients with SSc of more than ten years disease duration. CONCLUSION: PAH is a common complication of SSc. Physician adherence to PAH screening recommendations remains poor. Identifying modifiable barriers to screening may improve adherence and ultimately patient outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1250-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5341425
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53414252017-03-10 Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme Morrisroe, Kathleen Stevens, Wendy Sahhar, Joanne Rabusa, Candice Nikpour, Mandana Proudman, Susanna Arthritis Res Ther Research Article BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in this cohort, and an evaluation of factors influencing physician adherence to PAH screening guidelines. METHODS: Patient characteristics and results of PAH screening were determined in all patients enrolled in a SSc longitudinal cohort study. Adherence to PAH screening guidelines was assessed by a survey of Australian rheumatologists. Summary statistics, chi-square tests, univariate and multivariable logistic regression were used to determine the associations of risk factors with PAH. RESULTS: Among 1636 patients with SSc, 194 (11.9%) had PAH proven by right-heart catheter. Of these, 160 were detected by screening. The annual incidence of PAH was 1.4%. Patients with PAH diagnosed on subsequent screens, compared with patients in whom PAH was diagnosed on first screen, were more likely to have diffuse SSc (p = 0.03), be in a better World Health Organisation (WHO) Functional Class at PAH diagnosis (p = 0.01) and have less advanced PAH evidenced by higher mean six-minute walk distance (p = 0.03), lower mean pulmonary arterial pressure (p = 0.009), lower mean pulmonary vascular resistance (p = 0.006) and fewer non-trivial pericardial effusions (p = 0.03). Adherence to annual PAH screening using an ECHO-based algorithm was poor among Australian rheumatologists, with less than half screening their patients with SSc of more than ten years disease duration. CONCLUSION: PAH is a common complication of SSc. Physician adherence to PAH screening recommendations remains poor. Identifying modifiable barriers to screening may improve adherence and ultimately patient outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1250-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-07 2017 /pmc/articles/PMC5341425/ /pubmed/28270192 http://dx.doi.org/10.1186/s13075-017-1250-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Morrisroe, Kathleen
Stevens, Wendy
Sahhar, Joanne
Rabusa, Candice
Nikpour, Mandana
Proudman, Susanna
Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title_full Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title_fullStr Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title_full_unstemmed Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title_short Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
title_sort epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341425/
https://www.ncbi.nlm.nih.gov/pubmed/28270192
http://dx.doi.org/10.1186/s13075-017-1250-z
work_keys_str_mv AT morrisroekathleen epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT stevenswendy epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT sahharjoanne epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT rabusacandice epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT nikpourmandana epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT proudmansusanna epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme
AT epidemiologyanddiseasecharacteristicsofsystemicsclerosisrelatedpulmonaryarterialhypertensionresultsfromareallifescreeningprogramme